We are live on
!
Find out more
WCBA
Weaver C. Barksdale & Associates Portfolio holdings
AUM
$105M
1-Year Est. Return
13.81%
This Fund
S&P 500
This Quarter
Est. Return
+3.02%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$136M
AUM Growth
+$3.18M
(+2.4%)
Cap. Flow
+$1.47M
Cap. Flow
% of AUM
1.08%
Top 10 Holdings %
Top 10 Hldgs %
25.22%
Holding
589
New
35
Increased
200
Reduced
140
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ambarella
AMBA
|
+$2.95M |
| 2 |
Zebra Technologies
ZBRA
|
+$2.84M |
| 3 |
Qorvo
QRVO
|
+$2.82M |
| 4 |
CAVM
Cavium, Inc.
CAVM
|
+$2.7M |
| 5 |
Acadia Healthcare
ACHC
|
+$2.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$3.94M |
| 2 |
Under Armour
UAA
|
+$2.92M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$2.69M |
| 4 |
SBA Communications
SBAC
|
+$2.61M |
| 5 |
Applied Materials
AMAT
|
+$2.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.9% |
| 2 | Healthcare | 14.36% |
| 3 | Industrials | 12.22% |
| 4 | Consumer Discretionary | 11.44% |
| 5 | Consumer Staples | 8.29% |
Similar funds
EW
AFG
ANBOT
P
FCM
SPW
SHF
NS
Weaver C. Barksdale & Associates's Q2 2015 Portfolio in Review
As of Q2 2015, Weaver C. Barksdale & Associates held 589 positions worth $136M, up 2.4% from $133M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Weaver C. Barksdale & Associates's Q2 2015 filing shows 35 new, 200 increased, 140 reduced and 39 closed positions. Its largest new stake was Ambarella: 33,707 shares worth $3.46M. The largest sale was PHARMACYCLICS INC, an estimated $3.94M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.
- Weaver C. Barksdale & Associates's largest Q2 2015 buy was Ambarella: 33,707 shares worth $3.46M.
- Weaver C. Barksdale & Associates added most to Zebra Technologies in Q2 2015, an estimated $2.84M increase.
- Weaver C. Barksdale & Associates's biggest Q2 2015 reduction was LKQ Corp, cutting an estimated $2.47M.
- Weaver C. Barksdale & Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $3.94M.
- Weaver C. Barksdale & Associates's ten largest holdings make up 25% of its $136M portfolio in Q2 2015.
- Weaver C. Barksdale & Associates opened 35 new positions and closed 39 in Q2 2015.
- Weaver C. Barksdale & Associates's portfolio value rose 2.4% quarter-over-quarter to $136M.
Based on Weaver C. Barksdale & Associates's 13F filing for Q2 2015, filed 17 Jul 2015.